Designer drug use as reason for contradictions to work on vessel

Distribution and illegal trafficking of new psychoactive substances, related to designer drugs, create preconditions for growth in the number of potentially drug-addicted patients, including among students of maritime educational institutions and persons, belonging to crew personnel. Signs of drug addiction as well as the presence of drugs in the human body, psychotropic substances and their metabolites during medical check-ups, including chemical-toxicological studies, are the reasons for contradictions to work on the vessel. The article presents the review of a large group of synthetic narcotic drugs, related to designer drugs and differed in structure, mechanisms of toxicity, narcotic potential and behavioral disturbance. Classifications of designer drugs, different aspects of the problem of their use and prevalence in the population are considered. Mechanisms of a toxic effect of most prevalent designer drugs from groups of synthetic cannabinoids, synthetic cathinones and synthetic opioids are discussed.

1. Гордеев А. Ю. Современное состояние, тенденции наркотизма в России и система мер по его противодействию // Вопросы российского международного права. 2018. Т. 8, № 7А. С. 115–127 [Gordeev A. Yu. The current state of trends in narcotism in Russia and the system of measures aimed at its counteraction. Matters of Russian and International Law, 2018, Vol. 8, No. 7A, pp. 115–127 (In Russ.)].

2. Красинская Е. С. К вопросу профилактики наркомании и алкоголизма в подростковой среде // Modern science. 2019. № 5–1. С. 227–230 [Krasinskaya E. S. On the prevention of drug addiction and alcoholism in the adolescent environment // Modern science, 2019, No. 5–1, pp. 227–230 (In Russ.)].

3. Алексеев В. В., Шамрей В. К., Иванов А. М., Гончаренко А. Ю., Тихенко В. В. Мониторинг аддиктивного поведения военнослужащих: опыт использования методов химико-токсикологического исследования // Военно-медицинский журнал. 2016. Т. 337, № 3. С. 14–21 [Alekseev V. V., Shamrey V. K., Ivanov A. M., Goncharenko A. Yu., Tikhenko V. V. Addictive behavior monitoring in military personnel: an experience of chemical-toxicity study. Military medical journal, 2016, Vol. 337, No. 3, pp. 14–21 (In Russ.)].

4. Stepanov I., Abrams J., Jain V., Walter K., Kittner D.L. Variation of toxic and carcinogenic constituents in nasvai: call for systematic research and regulation. Tobacco Control, 2017, Vol. 26, No. 3, pp. 355–356. doi: 10.1136/tobaccocontrol-2016-052951.

5. Головко А. И., Иванов М. Б., Головко Е. С., Баринов В. А. Сведения о синтетических каннабиноидах, появившихся в незаконном обороте в 2016–2017 гг. // Наркология. 2018. Т. 17, № 3. С. 71–87 [Golovko A. I., Ivanov M. B., Golovko E. S., Barinov V. A. Information about synthetic cannabinoids, which appeared in the illicit trafficking in 2016–2017. Narcology, 2018, Vol. 17, No. 3, pp. 71–78 (In Russ.)].

6. Шилов А. И., Оноколов Ю. П. Проблемы алкоголизма и наркотизма в Вооруженных силах Российской Федерации // Человек: преступление и наказание. 2010. № 3 (70). С. 70–73 [Shilov A. I., Onokolov Yu. P. Alcohol and drug addiction in the armed forces of the Russian Federation. Person: crime and punishment, 2010, No. 3 (70), pp. 70–73 (In Russ.)].

7. Николаева Н. И., Алдошин В. В., Дашков Э. Ш. Профилактическая работа о вреде наркомании и алкоголизма как важный фактор развития личности будущего военного летчика // Проблемы современной науки и образования. 2016. № 30 (72). С. 92–97 [Nikolaeva N. I., Aldoshin V. V., Dashkov E. Sh. Preventive measures against drug and addiction as an important factor in future military pilot personality development. Problems of modern science and education, 2016, No. 30 (72), pp. 92–97 (In Russ.)].

8. Туровский И. В., Шилов А. И. Предупреждение наркотизма в Вооруженных силах США на современном этапе // Человек: преступление и наказание. 2012. № 4 (79). С. 169–172 [Turovsky I. V., Shilov A. I. Prevention of drug abuse in the US Armed Forces at the present stage. Person: crime and punishment, 2012, No. 4 (79), pp. 169–172 (In Russ.)].

9. Сопко В. В. Наркомания в армии и проблемы ее предупреждения в обстоятельствах, не связанных с боевой обстановкой // Территория науки. 2013. № 2. С. 283–286 [Sopko V. V. Drug addiction in the army and problems of its prevention un circumstances not related to the combat situation. Territory of science, 2013, No. 2, pp. 283–286 (In Russ.)].

10. Кувшинов К. Э., Алексеев В. В., Шамрей В. К., Марченко А. А., Гончаренко А. Ю., Лобачев А. В., Тихенко В. В., Пастушенков А. В. Профилактика аддиктивных расстройств в воинской части: методические рекомендации. СПб.: ВМедА. 2014. 28 с. [Kuvshinov K. E., Alekseev V. V., Shamrej V. K., Marchenko A. A., Goncharenko A. Yu., Lobachev A. V., Tichenko V. V., Pastushenkov A. V. Prevention of addictive disorders in military units: methodological recommendations. St. Petersburg: VMedA, 2014, 28 p. (In Russ.)].

11. Кувшинов К. Э., Алексеев В. В., Шамрей В. К., Марченко А. А., Гончаренко А. Ю., Лобачев А. В., Тихенко В. В., Пастушенков А. В. Раннее выявление и профилактика аддиктивных расстройств у военнослужащих: методические указания для врачей. СПб.: ВМедА. 2015. 74 с. [Kuvshinov K. E., Alekseev V. V., Shamrej V. K., Marchenko A. A., Goncharenko A. Yu., Lobachev A. V., Tichenko V. V., Pastushenkov A. V. Early detection and prevention of addictive disorders in military personnel: guidelines for doctors. St. Petersburg: VMedA, 2015. 74 p. (In Russ.)].

12. Тарумов Д. А., Марченко А. А., Малаховский В. Н., Ушаков В. Л., Гончаренко А. Ю., Мавренков Э. М., Труфанов А. Г., Литвинцев Б. С., Лобачев А. В., Исхаков Д. Н., Железняк И. С., Шамрей В. К., Фисун А. Я. Объективизация латентной наркологической патологии у потенциального воинского контингента с применением специальных методик магнитно-резонансной томографии // Вестник Российской военно-медицинской академии. 2019. № 3 (67). С. 13–25 [Tarumov D. A., Marchenko A. A., Malachovskiy V. N., Ushakov V. L., Goncharenko A. Yu., Mavrenkov E. M., Trufanov A. G., Litvintsev B. S., Lobachev A. V., Ischakov D. N., Zheleznyak I. S., Shamrej V. K., Fisun A. Ya. Objectification of latent narcological pathology in a potential military contingent using special magnetic resonance imaging techniques. Bulletin of the Russian military medical academy, 2019, No. 3 (67), pp. 13–25 (In Russ.)].

13. Мирошниченко Л. Д. Наркотики и наркомания. Энциклопедический словарь. М.: Перо. 2014. 404 с. [Miroshnichenko L. D. Drugs and Drug addiction. Encyclopedic dictionary. Moscow: Pero, 2014, 404 p. (In Russ.)].

14. Репина М. А., Павелец Д. А. ВИЧ-инфекция и материнская смертность // ВИЧ-инфекция и иммуносупрессии. 2019. Т. 11, № 4. С. 30–39 [Repina M. A., Pavelets D. A. HIV-infection and maternal mortality. HIV Infection and Immunosuppressive Disorders, 2019, Vol. 11, No. 4, pp. 30–39 (In Russ.)].

15. Симакина О. Е., Беляков Н. А., Рассохин В. В., Халезова Н. Б. Наркомания в распространении и формировании эпидемии инфекционных заболеваний // Морская медицина. 2020. Т. 6, № 2. С. 7–24 [Simakina O. E., Belyakov N. A., Rassokhin V. V., Khalezona N. B. Drug use in the spread and forming of epidemic of infectious disease. Marine medicine, 2020, Vol. 6, No. 2, pp. 7–24 (In Russ.)].

16. Головко А. И., Бонитенко Е. Ю., Башарин В. А., Иванов М. Б., Баринов В. А. Терминологические и биологические парадоксы феномена «дизайнерские наркотики» // Наркология. 2015. № 1. С. 69–83 [Golovko A. I., Bonitenko E. Yu., Basharin V. A., Ivanov M. B., Barinov V. A. Terminology and biological paradoxes of the phenomenon of «designer drugs». Narkologia, 2015, No. 1, pp. 69–83 (In Russ.)].

17. Baumeister D., Tojo L. M., Tracy D. K. Legal highs: staying on top of the flood of novel psychoactive substances. Ther. Adv. Psychopharmacol, 2015, Vol. 5, No. 2, pp. 97–132. doi: 10.1177/2045125314559539.

18. Kikura-Hanajiri R., Kawamura N. U., Goda Y. Changes in the prevalence of new psychoactive substances before and after the introduction of the generic scheduling of synthetic cannabinoids in Japan. Drug Test. Anal, 2014, Vol. 6, No. 7–8, pp. 832–839. doi: 10.1002/dta.1584.

19. The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) // Available at: http://www.emcdda.europa.eu/ Golovko A. I., Bonitenko E. Yu., Basharin V. A., Ivanov M. B., Barinov V. A. Narkologiya. 2015. № 1. S. 69–83. United Nations Office on Drugs and Crime (UNODC) 20. Global synthetic drugs assessment. UNODC. 2017. 81 p.

20. World Drug Report. 2017. Pt. 4. 60 p.

21. Glennon R.A. Arylalkylamine drugs of abuse: an overview of drug discrimination studies. Pharmacol. Biochem. Behav, 1999, Vol. 64, No. 2, pp. 251–256. doi: 10.1016/s0091-3057(99)00045-3.

22. EMCDDA–Europol 2013. Annual Report on the implementation of Council Decision 2005/387/JHA.

23. EMCDDA–Europol 2014. Annual Report on the implementation of Council Decision 2005/387/JHA.

24. Wikipedia, the Free Encyclopedia. List of designer drugs // Available at: https://en.wikipedia.org/wiki/List_of_designer_drugs (дата обращения 03.02.2023)

25. World Drug Report. 2017. Pt. 2. 68 p.

26. European Commission, Young People and Drugs, Flash Eurobarometer series. 2014. No. 401.162 p.

27. High-risk drug use and new psychoactive substances. EMCDDA, Luxembourg. 2017. 24 p.

28. American Association of Poison Control Centers. Synthetic cannabinoid data. 2015. 76 p.

29. EMCDDA–Europol Joint Report on a new psychoactive substance: 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl) indazole-3-carboxamide (CUMYL-4CN-BINACA), Joint Reports, Publications Office of the European Union, Luxembourg. 2017. 15 p.

30. Synthetic cannabinoids in Europe (Perspectives on drugs). EMCDDA, Lisbon, 2017, 9 p.

31. Suzuki J., El-Haddad S. A review: Fentanyl and non-pharmaceutical fentanyls. Drug Alcohol Depend, 2017, Vol. 171, P. 107–116. doi: 10.1016/j.drugalcdep.

32. World Drug Report. 2017, Pt. 1, 36 p.

33. Neuropharmacology of new psychoactive substances (NPS). The science behind the headlines. Curr. Topics Behav. Neurosci, 2017, Vol. 32, 380 p.

34. Howlett A. C., Barth F., Bonner T. I., Cabral G., Casellas P., Devane W. A., Felder C. C., Herkenham M., Mackie K., Martin B. R., Mechoulam R., Pertwee R. G. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol. Rev, 2002, Vol. 54, No. 2, pp. 161–202. doi: 10.1124/pr.54.2.161.

35. De Felice L. J., Glennon R. A., Negus S. S. Synthetic cathinones: chemical phylogeny, physiology, and neuropharmacology. Life Sci, 2014, Vol. 97, No. 1, pp. 20–26. doi: 10.1016/j.lfs.2013.10.029.

36. German C. L., Fleckenstein A. E., Hanson G. R. Bath salts and synthetic cathinones: an emerging designer drug phenomenon. Life Sci, 2014, Vol. 97, No. 1, pp. 2–8. doi: 10.1016/j.lfs.2013.07.023.

37. Glennon R. A. Bath salts, mepedrone, and methylenedioxypyrovalerone as emerging illicit drugs that will need targeted therapeutic intervention. Adv. Pharmacol, 2014, Vol. 69, pp. 581–620. doi: 10.1016/B978-0-12-420118-7.00015-9.

38. Methamphetamine. A European Union perspective in the global context. EMCDDA. 2009. 32 p.

39. Nelson M. E., Bryant S. M., Aks S. E. Emerging drugs of abuse. Emerg. Med. Clin. North Am, 2014, Vol. 32, No. 1, pp. 1–28. doi: 10.3109/15563650.2012.740637.

40. Misailidi N., Papoutsis I., Nikolaou P., Dona A., Spiliopoulou C., Athanaselis S. Fentanyls continue to replace heroin in the drug arena: the cases of ocfentanil and carfentanil. Forensic Toxicol, 2018, Vol. 36, No. 1, pp. 1–11. doi: 10.1007/s11419-017-0379-4.

41. Ujváry I., Jorge R., Christie R., Le Ruez T., Danielsson H. V., Kronstrand R., Elliott S., Gallegos A., Sedefov R., Evans-Brown M. Acryloylfentanyl, a recently emerged new psychoactive substance: a comprehensive review. Forensic Toxicol, 2017, Vol. 35, No. 2, pp. 232–243. doi:10.1007/s11419-017-0367-8.

42. History of heroin. UNODC, 1953, 13 p.

43. Zheluk A., Quinn C., Meylakhs P. Internet search and krokodil in the Russian Federation: an infoveillance study. J. Med. Internet Res, 2014, Vol. 16, No. 9. Article e212. 72 p. doi: 10.2196/jmir.3203.

44. Fentanyl and its analogues - 50 years. UNODC, 2017, 12 p.

45. Gladden R. M., Martinez P., Seth P. Fentanyl law enforcement submissions and increases in synthetic opioid-involved overdose deaths - 27 States, 2013-2014. MMWR Morb. Mortal. Wkly. Rep, 2016, Vol. 65, No. 33, pp. 837–843. doi: 10.15585/mmwr.mm6533a2.

46. O’Donnell J. K., Gladden R. M., Seth P. Trends in deaths involving heroin and synthetic opioids excluding methadone, and law enforcement drug product reports, by census region - United States, 2006-2015. MMWR Morb. Mortal. Wkly. Rep, 2017, Vol. 66, No. 34, pp. 897–903. doi: 10.15585/mmwr.mm6634a2.

47. Dhawan B. N., Cesselin F., Raghubir R., Reisine T., Bradley P. B., Portoghese P. S., Hamon M. International Union of Pharmacology. XII. Classification of opioid receptors. Pharmacol. Rev, 1996, Vol. 48, No. 4, pp. 567–592.